Integrated multi-omic profiling enables recurrence risk stratification beyond pathological stage in resected EGFR-mutant lung adenocarcinoma.
- DOI
- 10.1016/j.jtho.2026.104204
- Published
- 2026 Sep 16
- Container
- Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.jtho.2026.104204,
title = {Integrated multi-omic profiling enables recurrence risk stratification beyond pathological stage in resected EGFR-mutant lung adenocarcinoma.},
author = {Saw SPL and Pang M and Yeo JC and Alvarez JJS and Sim NL and Guo AY and Kadioglu S and Lau ELY and Lau YT and Odinokov D and Getty V and Lai GGY and Lim DWT and Kanesvaran R and Ang MK and Ng QS and Tan WL and Tan WC and Tan AC and Wong SYN and Seet AOL and Hoo R and Ong BH and Lim TKH and Skanderup AJ and Tan DSW},
year = {2026},
journal = {Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer},
doi = {10.1016/j.jtho.2026.104204},
url = {https://doi.org/10.1016/j.jtho.2026.104204}
}RIS
TY - JOUR TI - Integrated multi-omic profiling enables recurrence risk stratification beyond pathological stage in resected EGFR-mutant lung adenocarcinoma. AU - Saw SPL AU - Pang M AU - Yeo JC AU - Alvarez JJS AU - Sim NL AU - Guo AY AU - Kadioglu S AU - Lau ELY AU - Lau YT AU - Odinokov D AU - Getty V AU - Lai GGY AU - Lim DWT AU - Kanesvaran R AU - Ang MK AU - Ng QS AU - Tan WL AU - Tan WC AU - Tan AC AU - Wong SYN AU - Seet AOL AU - Hoo R AU - Ong BH AU - Lim TKH AU - Skanderup AJ AU - Tan DSW PY - 2026 JO - Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer DO - 10.1016/j.jtho.2026.104204 UR - https://doi.org/10.1016/j.jtho.2026.104204 ER -
APA
SPL, S., M, P., JC, Y., JJS, A., NL, S., AY, G., S, K., ELY, L., YT, L., D, O., V, G., GGY, L., DWT, L., R, K., MK, A., QS, N., WL, T., WC, T., AC, T., SYN, W., AOL, S., R, H., BH, O., TKH, L., AJ, S., & DSW, T. (2026). Integrated multi-omic profiling enables recurrence risk stratification beyond pathological stage in resected EGFR-mutant lung adenocarcinoma.. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer. https://doi.org/10.1016/j.jtho.2026.104204
Source records
- pubmed · retrieved 2026-09-25T14:41:43.028Z